Two Sigma Securities’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,360
Closed -$57.8K 1620
2025
Q4
$57.8K Buy
3,360
+1,729
+106% +$33.5K 0.01% 1049
2025
Q3
$42K Buy
+1,631
New +$61.6K 0.01% 1016
2025
Q2
Sell
-486
Closed -$52.7K 1458
2025
Q1
$52.7K Buy
+486
New +$42.3K 0.01% 1001
2024
Q4
Sell
-467
Closed -$28.2K 1612
2024
Q3
$45.9K Sell
467
-127
-21% -$16.4K ﹤0.01% 2388
2024
Q2
$97.1K Buy
+594
New +$84.6K ﹤0.01% 2484

Other funds holding AGL

Two Sigma Securities's AGL Position: Q1 2026 in Review

Two Sigma Securities sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 3,360 shares — an estimated $57.8K sold.

Two Sigma Securities first reported a position in AGL in Q2 2024 and held it in 5 quarters. The position peaked at $97.1K in Q2 2024. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Two Sigma Securities reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 3,360 Agilon Health shares in Q1 2026, an estimated $57.8K.
  • Two Sigma Securities first reported a position in Agilon Health in Q2 2024 and held it in 5 quarters.
  • Two Sigma Securities's Agilon Health position peaked at $97.1K in Q2 2024.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.